Weigao Group was founded in 1988. It focuses on disposable medical devices and drugs and has developed five major industries including aerospace and military industry, real estate, and securities investment. It covers an area of ??more than 2 million square meters and has a total It has assets of more than 10 billion yuan, more than 12,000 employees, and 20 subsidiaries. Its holding subsidiary Shandong Weigao Group Medical Polymer Products Co., Ltd. was listed on the Hong Kong GEM in February 2004 and transferred to the main board in July 2010. The group has more than 300 kinds and more than 30,000 specifications of medical devices and drugs, mainly including infusion consumables, surgical sutures, medical catheters, cardiac stents and intracardiac consumables, indwelling needles and various special-shaped needles, blood purification equipment and consumables, orthopedics Materials, medical equipment, therapeutic injections and other drugs, biological diagnostic reagents, artificial plasma, biological implants, PVC and non-PVC raw materials, etc., becoming China's largest disposable medical device manufacturer and a national 863 industrialization base , a key high-tech enterprise of the National Torch Plan, and has been honored as an industry leader, a national contract-abiding and trustworthy enterprise, one of the top 500 most competitive Chinese large enterprise groups, one of the top 500 Chinese enterprise informatization companies, one of China's Patented Shandong Star Enterprises, and one of China's Most Powerful Bidding Companies No. 1 medical device brand supplier, Shandong Province Industry-University-Research Cooperation Innovation Outstanding Contribution Award, Shandong Province Top 100 Enterprises, Shandong Province Best Corporate Citizen, Shandong Province's first batch of integrity demonstration enterprises and other honorary titles.
The company has a sound technological innovation system and has a national enterprise technology center, a national engineering laboratory, an academician workstation, a postdoctoral research workstation, and a provincial enterprise technology center. Adhering to the path of industry-university-research cooperation, we have cooperated with the Chinese Academy of Sciences and the Changchun, Dalian, and Shenyang Institutes of the Chinese Academy of Sciences, 301 Hospital, Third Military Medical University, Harbin Institute of Technology, Shenyang Pharmaceutical University and other units to establish 9 Weigao R&D centers in different places, vigorously developing independent High-tech content and high value-added products of intellectual property. In 2010, we jointly implemented the Chinese Academy of Sciences-Weigao Group high-tech research and development plan with the Chinese Academy of Sciences. At present, Weigao has more than 200 patented products, of which more than 80 products have filled domestic gaps and reached advanced levels at home and abroad, breaking the monopoly of multinational companies. More than 20 projects (cardiac stents, polysulfone membrane dialyzers, spinal internal fixation , central venous catheters, gene protein A immunoadsorption columns, self-destructive safety syringes, plasma separators, light-proof syringes, etc.) have been included in the National Key Torch Plan, the National 863 Plan, the National High-tech Industry Demonstration Project, and the National Key New products and other national planning projects.
Weigao Group unremittingly implements the famous brand strategy and cultivates well-known brands. The "Jierui" trademark was recognized as "China's Well-known Trademark", "Jierui Brand Disposable Sterile Infusion Medical Device" was awarded the title of "China Famous Brand Product", and the "Jierui" brand was rated as one of China's top brands by the China Brand Research Institute The number one brand of medical devices. The company has established more than 100 sales offices in more than 30 provinces, municipalities, and autonomous regions across the country, and has established long-term and stable relationships with more than 7,000 hospitals, more than 400 blood stations, and more than 1,800 commercial companies across the country. The company's products not only sell well in more than 30 domestic provinces, municipalities, and autonomous regions, but are also directly exported to more than 50 countries and regions such as the United States, the European Union, Russia, South Africa, and Brazil.
Weigao Group actively participates in social welfare and charity and actively repays the society. In recent years, Weigao Bright Action, Weigao Love Project, selection of top ten filial piety stars, subscription of charity funds, natural disaster donations and other activities have been carried out, with a total of more than 200 million yuan in donations.
Weigao takes "together with the messengers in white to create a healthy future" as its mission, establishes the core corporate values ??of conscience, sincerity and loyalty, builds a century-old evergreen foundation, and strives to become "world competitive, Asia-leading, The vision goal of "the most respected medical device and pharmaceutical enterprise" is making great strides, and it will make greater contributions to promoting the healthy development of my country's medical and health industry.